baicalin has been researched along with rolipram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Byun, HD; Choi, JS; Choi, Y; Han, JH; Kim, SG; Lee, JS; Nam, YJ; Oh, JS; Park, K; Song, MJ | 1 |
2 other study(ies) available for baicalin and rolipram
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Identification and Characterization of Baicalin as a Phosphodiesterase 4 Inhibitor.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Flavonoids; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Phosphodiesterase 4 Inhibitors; Plant Extracts; RAW 264.7 Cells; Rolipram; Rosaceae; Tumor Necrosis Factor-alpha | 2016 |